Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafni Birmpili

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|October 14, 2022
The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical UseDafni Birmpili, Imane Charmarke Askar, Kévin Bigaut, et al.
International Journal of Molecular Sciences|November 26, 2022
Toward a Combination of Biomarkers for Molecular Characterization of Multiple SclerosisDafni Birmpili, Imane Charmarke Askar, Lucas Dinh Pham-Van, et al.
Cells|July 6, 2023
Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform OligomerisationThomas Kuntzel, Caroline Spenlé, Lucas D Pham-Van, et al.
Neurobiology of Disease|June 6, 2024
Fluorinated apelin-13 mediates neuroprotective effects in multiple sclerosis modelsDafni Birmpili, Imane Charmarké-Askar, Caroline Spenlé, et al.
EMBO Molecular Medicine|October 1, 2019
Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelinationFabien Binamé, Lucas D Pham-Van, Caroline Spenlé, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|October 14, 2022
The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical UseDafni Birmpili, Imane Charmarke Askar, Kévin Bigaut, et al.
International Journal of Molecular Sciences|November 26, 2022
Toward a Combination of Biomarkers for Molecular Characterization of Multiple SclerosisDafni Birmpili, Imane Charmarke Askar, Lucas Dinh Pham-Van, et al.
Cells|July 6, 2023
Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform OligomerisationThomas Kuntzel, Caroline Spenlé, Lucas D Pham-Van, et al.
Neurobiology of Disease|June 6, 2024
Fluorinated apelin-13 mediates neuroprotective effects in multiple sclerosis modelsDafni Birmpili, Imane Charmarké-Askar, Caroline Spenlé, et al.
EMBO Molecular Medicine|October 1, 2019
Disruption of Sema3A/Plexin-A1 inhibitory signalling in oligodendrocytes as a therapeutic strategy to promote remyelinationFabien Binamé, Lucas D Pham-Van, Caroline Spenlé, et al.
Pageof 1